Literature DB >> 8651252

Modification of disease progression in rats with inherited polycystic kidney disease.

B D Cowley1, J J Grantham, M J Muessel, A L Kraybill, V H Gattone.   

Abstract

The most common inherited form of human polycystic kidney disease (PKD), autosomal dominant PKD (ADPKD), is a leading cause of chronic renal failure, but has a variable clinical presentation, with end-stage renal disease occurring in only 25% to 75%. Several findings are consistent with the idea that factors in addition to the primary mutation can affect the progression of cystic change and chronic renal failure in PKD. Epithelial cell proliferation is a central element in the pathogenesis of renal cysts. We postulated that the superimposition of a growth-promoting stimulus might promote more intense proliferation of cystic epithelial cells in inherited cystic disease. To study this, we subjected Han:SPRD rats, with a form of ADPKD that resembles human ADPKD, from 4 until 10 weeks of age to diets designed to promote tubule cell growth. The diets included supplemental NH4Cl (280 mmol/L in drinking water), limited dietary K+ (0.016% of diet; control diet was 1.1% K+), and increased dietary protein (50%; control diet was 23% protein). Treatments designed to promote cell growth caused more aggressive PKD in males and females, worsened azotemia in males, and resulted in azotemia in females (which normally develop PKD but not azotemia at the ages studied). NH4Cl, K+ restriction, and increased dietary protein each caused greater kidney enlargement in males (kidney weight/body weight ratios increased by 35%, 78%, and 105%, respectively) and worsened azotemia in males (serum urea nitrogen values increased by 63%, 514%, and 224%, respectively); in contrast, decreased dietary protein (4%) caused less severe PKD in males (kidney weight/body weight ratios decreased by 43%) and lessened azotemia in males (serum urea nitrogen values decreased by 49%). Similarly, NH4Cl and K+ restriction caused greater kidney enlargement in females (kidney weight/body weight ratios increased by 206% and 203%, respectively) and caused azotemia in females (serum urea nitrogen values increased by 177% and 430%, respectively). On the basis of these results, we conclude that growth-promoting stimuli can alter the expression of hereditary renal cystic disease. These findings demonstrate that the progression of hereditary renal cystic disease can be altered by factors in addition to the primary genetic defect.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8651252     DOI: 10.1016/s0272-6386(96)90525-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  19 in total

1.  Pathogenesis of arrhythmias in a model of CKD.

Authors:  Chia-Hsiang Hsueh; Neal X Chen; Shien-Fong Lin; Peng-Sheng Chen; Vincent H Gattone; Matthew R Allen; Michael C Fishbein; Sharon M Moe
Journal:  J Am Soc Nephrol       Date:  2014-05-22       Impact factor: 10.121

2.  A rat model of chronic kidney disease-mineral bone disorder.

Authors:  Sharon M Moe; Neal X Chen; Mark F Seifert; Rachel M Sinders; Dana Duan; Xianming Chen; Yun Liang; J Scott Radcliff; Kenneth E White; Vincent H Gattone
Journal:  Kidney Int       Date:  2008-09-17       Impact factor: 10.612

3.  Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions.

Authors:  Christopher L Newman; Neal X Chen; Eric Smith; Mark Smith; Drew Brown; Sharon M Moe; Matthew R Allen
Journal:  Bone       Date:  2015-04-17       Impact factor: 4.398

4.  Adverse mandibular bone effects associated with kidney disease are only partially corrected with bisphosphonate and/or calcium treatment.

Authors:  Matthew R Allen; Neal X Chen; Vincent H Gattone; Sharon M Moe
Journal:  Am J Nephrol       Date:  2013-11-22       Impact factor: 3.754

5.  Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.

Authors:  M R Allen; N X Chen; V H Gattone; X Chen; A J Carr; P LeBlanc; D Brown; S M Moe
Journal:  Osteoporos Int       Date:  2012-08-21       Impact factor: 4.507

6.  Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.

Authors:  Neal I Alcalay; Madhulika Sharma; Dianne Vassmer; Brandon Chapman; Binu Paul; Jing Zhou; Jennifer G Brantley; Darren P Wallace; Robin L Maser; Gregory B Vanden Heuvel
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-01

7.  Subcutaneous nerve activity and mechanisms of sudden death in a rat model of chronic kidney disease.

Authors:  Ye Zhao; Neal X Chen; Jonathan T Shirazi; Changyu Shen; Shien-Fong Lin; Michael C Fishbein; Sharon M Moe; Peng-Sheng Chen
Journal:  Heart Rhythm       Date:  2015-12-29       Impact factor: 6.343

Review 8.  Recent advances in understanding the pathogenesis of polycystic kidney disease: therapeutic implications.

Authors:  Benjamin D Cowley
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 9.  Kidney Disease and Bone: Changing the Way We Look at Skeletal Health.

Authors:  Matthew R Allen; Elizabeth A Swallow; Corinne E Metzger
Journal:  Curr Osteoporos Rep       Date:  2020-06       Impact factor: 5.096

10.  The Jeremiah Metzger Lecture. Polycystic kidney disease: old disease in a new context.

Authors:  Jared J Grantham
Journal:  Trans Am Clin Climatol Assoc       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.